CD158b, which is typically confined to NK cells (or some CD8+TCRαβ+ effector T cells), appeared to be mainly expressed in CD4+NKG2D+ T cells when this population was underrepresented (range 0–2 %) in both control and cervical cancer groups (data not shown). The gene discussed is CD4; the disease is cervical carcinoma.